Skip to main content

Table 1 Associations between TBIL level and clinical characteristics in CRC patients

From: A nomogram based on pretreatment levels of serum bilirubin and total bile acid levels predicts survival in colorectal cancer patients

Variable

 

TBIL group

Statistics

P

 

Low DBIL (n), %

High DBIL (n), %

Sex

Male

239 (56.5)

628 (59.8)

1.316

0.251

Femal

184 (43.5)

423 (40.2)

  

Age

 

57.68 ± 12.51

58.23 ± 12.05

−0.776

0.438

Somking

Yes

91 (21.5)

212 (20.2)

0.332

0.564

No

332 (778.5)

839 (79.8)

  

Tumor history

Yes

43 (10.2)

113 (10.8)

0.11

0.741

No

380 (79.8)

938 (89.2)

  

Obstruction

Yes

68 (16.1)

170 (16.2)

0.002

0.963

No

355 (83.9)

881 (83.8)

  

Tumor size (cm)

4.42 ± 2.02

4.09 ± 2.11

2.641

0.008

Tumor location

Right colon

138 (32.6)

313 (29.8)

2.791

0.248

Left colon

88 (20.8)

198 (18.8)

  

Rectum

197 (46.6)

540 (51.4)

  

Differentiation (%)

Well

56 (13.2)

165 (15.7)

1.445

0.486

Moderate

339 (80.1)

820 (78.0)

  

Poor

28 (6.6)

66 (6.3)

  

T stage (%)

T1

36 (13.3)

72 (6.9)

3.926

0.27

T2

70 (16.5)

169 (16.1)

  

T3

232 (54.8)

553 (52.6)

  

T4

85 (20.1)

257 (24.5)

  

N stage (%)

N0

265 (62.6)

579 (55.1)

7.338

0.026

N1

91 (21.5)

284 (27.0)

  

N2

67 (15.8)

188 (17.9)

  

TNM stage (%)

I

58 (13.7)

139 (13.2)

2.973

0.096

II

155 (36.6)

347 (33.0)

  

III

162 (38.3)

418 (39.8)

  

IV

48 (11.3)

147 (14.0)

  

Perineural invasion(%)

Yes

94 (22.2)

225 (21.4)

0.118

0.731

No

329 (77.8)

826 (78.6)

  

Vascular invasion (%)

Yes

77 (18.2)

188 (17.9)

0.02

0.887

No

346 (81.8)

863 (82.1)

  

Chemotherapy (%)

Yes

226 (18.2)

556 (52.9)

0.033

0.855

No

197 (46.6)

495 (47.1)

  
  1. TBIL total bilirubin, CRC Colorectal Cancer